Kirin Company
Search results
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases.
The global speciality pharmaceutical innovator, Kyowa Kirin makes drugs that make headlines. The company’s rich pipeline contains candidate treatments for cancer, kidney disease, immune system diseases, and central nervous system diseases.
Jan 1, 2024 · August 01, 2024 Announcement regarding the restructuring of APAC region business and Change in a Specified Subsidiary （138KB）. August 01, 2024 Consolidated Financial Summary (IFRS) Fiscal 2024 Semi Annual （667KB）. more. Introduction of Kyowa Kirin Co., Ltd. Investor Relations.
Across North America and around the globe, Kyowa Kirin strives to create and deliver novel medicines with life-changing value. We are a Japan-based global specialty pharmaceutical company that uses cutting-edge science to address the needs of patients across multiple therapeutic areas.
Advance your career in pharmaceutical technology including pharmaceutical research, manufacturing, drug and product development, and more. Our growth relies on sharing expertise and ideas in ways that prioritize innovation, diversity, teamwork, and integrity. Join us to create a profound impact.
Jan 1, 2024 · Consolidated Financial Summary Fiscal 2022 First Quarter （734KB）. Appendix to the Consolidated Financial Summary Fiscal 2022 First Quarter （833KB）. Results Presentation Fiscal 2022 First Quarter （708KB）. Transcript of Results Briefing Fiscal 2022 First Quarter (text) （2,879KB）.
Kyowa Kirin pursues scientific breakthroughs to address unmet clinical needs. Learn more about our portfolio of specialty medicines in nephrology, oncology, immunology & allergy, and neurology. Join us to grow your career or partner with us to propel your research discoveries into the hands of patients and physicians.
At Kyowa Kirin, our Core Values drive us to do everything we can to answer the needs of patients, their families, and medical professionals. We act consistently with these Core Values in mind – Commitment to Life, Innovation, Integrity, and Teamwork/Wa.
The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. Since the early 2000s, Kyowa Kirin has been present in Malaysia with our innovative medicines designed to alleviate suffering and restore health to patients.
Nov 14, 2023 · Kyowa Kirin practices CSV management aimed at realizing improved corporate value through the creation of both social and economic value.
